Patents by Inventor Michal Zimecki

Michal Zimecki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10238713
    Abstract: There are provided compounds of formula I: wherein k, m, n, p, R, R?, R?, R??, R3, R4, R7 and R8 are as defined in the application. Other embodiments are also disclosed.
    Type: Grant
    Filed: July 4, 2016
    Date of Patent: March 26, 2019
    Assignees: LODZ UNIVERSITY OF TECHNOLOGY, PEPTADERM SP. Z O.O.
    Inventors: Janusz Zabrocki, Michal Zimecki, Andrzej Kaszuba, Krzysztof Kaczmarek
  • Publication number: 20170157204
    Abstract: There are provided compounds of formula I: wherein k, m, n, p, R, R?, R?, R??, R3, R4, R7 and R8 are as defined in the application. Other embodiments are also disclosed.
    Type: Application
    Filed: July 4, 2016
    Publication date: June 8, 2017
    Inventors: Janusz ZABROCKI, Michal ZIMECKI, Andrzej KASZUBA, Krzysztof KACZMAREK
  • Patent number: 9382292
    Abstract: There are provided compounds of formula I: wherein k, m, n, p, R, R?, R?, R??, R3, R4, R7 and R8 are as defined in the application. Other embodiments are also disclosed.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: July 5, 2016
    Inventors: Janusz Zabrocki, Michal Zimecki, Andrzej Kaszuba, Krzysztof Kaczmarek
  • Publication number: 20130224232
    Abstract: There are provided compounds of formula I wherein k, m, n, p, R, R?, R?, R??, R3 and R4 are as defined in the application. Other embodiments are also disclosed.
    Type: Application
    Filed: February 19, 2011
    Publication date: August 29, 2013
    Inventors: Janusz Zabrocki, Michal Zimecki, Andrzij Kaszuba, Krzysztof Kaczmarek
  • Publication number: 20130108655
    Abstract: There are provided compounds of formula I: wherein k, m, n, p, R, R?, R?, R??, R3, R4, R7 and R8 are as defined in the application. Other embodiments are also disclosed.
    Type: Application
    Filed: August 24, 2012
    Publication date: May 2, 2013
    Inventors: Janusz ZABROCKI, Michal ZIMECKI, Andrzej KASZUBA, Krzysztof KACZMAREK
  • Patent number: 7691809
    Abstract: The method of the present invention provides a novel use of lactoferrin to modulate the molecular events during development of age-related disorders in humans. More specifically, the present invention is directed to the use of lactoferrin to treat or prevent autoimmune, neurodegenerative and immune hypersensitivity disorders, and its use for the manufacture of a medicament for the treatment or prevention of such conditions.
    Type: Grant
    Filed: January 22, 2005
    Date of Patent: April 6, 2010
    Assignee: Vitaerx Pharmaceutical, Inc.
    Inventors: Marian L. Kruzel, Tadeusz Kruzel, Michal Zimecki
  • Publication number: 20070161541
    Abstract: The present invention is directed to the use of lactoferrin for alleviation of immune dissonance due to age-related and chronic conditions such as autoimmune disease, neurodegenerative and immune hypersensitivity conditions.
    Type: Application
    Filed: March 10, 2007
    Publication date: July 12, 2007
    Inventors: Marian Kruzel, Tadeusz Kruzel, Michal Zimecki, Istvan Boldgh
  • Publication number: 20050159340
    Abstract: The method of the present invention provides a novel use of lactoferrin to modulate the molecular events during development of age-related disorders in humans. More specifically, the present invention is directed to the use of lactoferrin to treat or prevent autoimmune, neurodegenerative and immune hypersensitivity disorders, and its use for the manufacture of a medicament for the treatment or prevention of such conditions.
    Type: Application
    Filed: January 22, 2005
    Publication date: July 21, 2005
    Inventors: Marian Kruzel, Tadeusz Kruzel, Michal Zimecki
  • Publication number: 20030096736
    Abstract: The method of the present invention provides a novel use of lactoferrin to modulate the molecular events during development of autoimmune and/or neurodegenerative disorders in humans. More specifically, the present invention is directed to the use of lactoferrin to treat or prevent age related disorders such as Alzheimer's disease, multiple sclerosis, rheumatoid arthritis, stroke or chronic fatigue syndrom, and its use for the manufacture of a medicament for the treatment or prevention of such disorders.
    Type: Application
    Filed: May 7, 2002
    Publication date: May 22, 2003
    Inventors: Marian L. Kruzel, Tadeusz Kruzel, Michal Zimecki